{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:11:24Z","timestamp":1793725884719,"version":"4.6.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007660","name":"Universiteit Antwerpen","doi-asserted-by":"publisher","award":["41\/FA020000\/FFB140317"],"award-info":[{"award-number":["41\/FA020000\/FFB140317"]}],"id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["42\/FA020000\/685"],"award-info":[{"award-number":["42\/FA020000\/685"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Currently, the\u00a0evidence on synaptic abnormalities in neuropsychiatric disorders\u2014including obsessive\u2013compulsive disorder (OCD)\u2014is emerging. The newly established positron emission tomography (PET) ligand ((R)-1-((3-((11)C-methyl-(11)C)pyridin-4-yl)methyl)-4-(3,4,5-trifluorophenyl)pyrrolidin-2-one) ([<jats:sup>11<\/jats:sup>C]UCB-J) provides the opportunity to visualize synaptic density changes in vivo, by targeting the synaptic vesicle protein 2A (SV2A). Here, we aim to evaluate such alterations in the brain of the SAP90\/PSD-95-associated protein 3 (Sapap3) knockout (ko) mouse model, showing an abnormal corticostriatal neurotransmission resulting in OCD-like behaviour.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Longitudinal [<jats:sup>11<\/jats:sup>C]UCB-J \u00b5PET\/CT scans were acquired in Sapap3 ko and wildtype (wt) control mice (<jats:italic>n<\/jats:italic>\u2009=\u20099\/group) to study SV2A availability. Based on the Logan reference method, we calculated the volume of distribution (<jats:italic>V<\/jats:italic><jats:sub>T(IDIF)<\/jats:sub>) for [<jats:sup>11<\/jats:sup>C]UCB-J. Both cross-sectional (wt vs. ko) and longitudinal (3 vs. 9\u00a0months) volume-of-interest-based statistical analysis and voxel-based statistical parametric mapping were performed. Both [<jats:sup>11<\/jats:sup>C]UCB-J ex vivo autoradiography and [<jats:sup>3<\/jats:sup>H]UCB-J in vitro autoradiography were used for the\u00a0validation of the \u00b5PET data.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>At the age of 3\u00a0months, Sapap3 ko mice are already characterized by a significantly lower SV2A availability compared to wt littermates (i.a. cortex \u2212\u00a012.69%, <jats:italic>p\u2009&lt;<\/jats:italic>\u20090.01; striatum \u2212 14.12%, <jats:italic>p\u2009&lt;<\/jats:italic>\u20090.001, thalamus \u2212 13.11%, <jats:italic>p\u2009&lt;<\/jats:italic>\u20090.001, and hippocampus\u00a0\u2212\u00a012.99%,<jats:italic> p<\/jats:italic>\u00a0&lt;\u00a00.001). Healthy ageing in control mice was associated with a diffuse and significant (<jats:italic>p\u2009&lt;<\/jats:italic>\u20090.001) decline throughout the brain, whereas in Sapap3 ko mice this decline was more confined to the corticostriatal level. A strong linear relationship (<jats:italic>p\u2009&lt;<\/jats:italic>\u20090.0001) was established between the outcome parameters of [<jats:sup>11<\/jats:sup>C]UCB-J \u00b5PET and [<jats:sup>11<\/jats:sup>C]UCB-J ex vivo autoradiography, while such relationship was absent for [<jats:sup>3<\/jats:sup>H]UCB-J in vitro autoradiography.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>[<jats:sup>11<\/jats:sup>C]UCB-J PET is a potential marker for synaptic density deficits in the Sapap3 ko mouse model for OCD, parallel to disease progression. Our data suggest that [<jats:sup>11<\/jats:sup>C]UCB-J ex vivo autoradiography is a suitable proxy for [<jats:sup>11<\/jats:sup>C]UCB-J PET data in mice.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13550-020-00721-2","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T12:02:37Z","timestamp":1605268957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Sapap3 deletion causes dynamic synaptic density abnormalities: a longitudinal [11C]UCB-J PET study in a model of obsessive\u2013compulsive disorder-like behaviour"],"prefix":"10.1186","volume":"10","author":[{"given":"Dorien","family":"Glorie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Verhaeghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stef","family":"De Lombaerde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Stroobants","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Staelens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,13]]},"reference":[{"key":"721_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2008.94","author":"AM Ruscio","year":"2010","unstructured":"Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010. https:\/\/doi.org\/10.1038\/mp.2008.94.","journal-title":"Mol Psychiatry"},{"key":"721_CR2","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0140-6736(09)60240-3","volume":"374","author":"JS Abramowitz","year":"2009","unstructured":"Abramowitz JS, Taylor S, McKay D. Obsessive-compulsive disorder. Lancet. 2009;374:491\u20139.","journal-title":"Lancet"},{"key":"721_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-863","author":"CJ Murray","year":"1996","unstructured":"Murray CJ, Lopez A. A comprehensive assessment of mortality and disability from disease, injures and risk factors in 1990 and projected to 2020. Glob Burd Dis. 1996. https:\/\/doi.org\/10.1186\/1471-2458-13-863.","journal-title":"Glob Burd Dis"},{"key":"721_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0896-6273(00)00113-6","volume":"28","author":"AM Graybiel","year":"2000","unstructured":"Graybiel AM, Rauch SL. Toward a neurobiology of obsessive-compulsive disorder. Neuron. 2000;28:343\u20137.","journal-title":"Neuron"},{"key":"721_CR5","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nrn3746","volume":"15","author":"DL Pauls","year":"2014","unstructured":"Pauls DL, Abramovitch A, Rauch SL, Geller DA. Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective. Nat Rev Neurosci. 2014;15:410\u201324.","journal-title":"Nat Rev Neurosci"},{"key":"721_CR6","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.conb.2011.04.010","volume":"21","author":"JT Ting","year":"2011","unstructured":"Ting JT, Feng G. Neurobiology of obsessive-compulsive disorder: insights into neural circuitry dysfunction through mouse genetics. Curr Opin Neurobiol. 2011;21:842\u20138.","journal-title":"Curr Opin Neurobiol"},{"key":"721_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-016-0729-7","author":"I Frydman","year":"2016","unstructured":"Frydman I, de Salles Andrade JB, Vigne P, Fontenelle LF. Can neuroimaging provide reliable biomarkers for obsessive-compulsive disorder? A narrative review. Curr Psychiatry Rep. 2016. https:\/\/doi.org\/10.1007\/s11920-016-0729-7.","journal-title":"Curr Psychiatry Rep"},{"key":"721_CR8","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.2.228","author":"D Mataix-Cols","year":"2005","unstructured":"Mataix-Cols D, Do Rosario-Campos MC, Leckman JF. A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry. 2005. https:\/\/doi.org\/10.1176\/appi.ajp.162.2.228.","journal-title":"Am J Psychiatry"},{"key":"721_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2015.11.009","author":"SE Ahmari","year":"2016","unstructured":"Ahmari SE. Using mice to model obsessive compulsive disorder: from genes to circuits. Neuroscience. 2016. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.11.009.","journal-title":"Neuroscience"},{"key":"721_CR10","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2010.122","author":"D Denys","year":"2010","unstructured":"Denys D, Mantione M, Figee M, Van Den Munckhof P, Koerselman F, Westenberg H, Bosch A, Schuurman R. Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder. Arch Gen Psychiatry. 2010. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2010.122.","journal-title":"Arch Gen Psychiatry"},{"key":"721_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/nature06104","author":"JM Welch","year":"2007","unstructured":"Welch JM, Lu J, Rodriguiz RM, et al. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature. 2007. https:\/\/doi.org\/10.1038\/nature06104.","journal-title":"Nature"},{"key":"721_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2017.180","author":"N Nagarajan","year":"2018","unstructured":"Nagarajan N, Jones BW, West PJ, Marc RE, Capecchi MR. Corticostriatal circuit defects in Hoxb8 mutant mice. Mol Psychiatry. 2018. https:\/\/doi.org\/10.1038\/mp.2017.180.","journal-title":"Mol Psychiatry"},{"key":"721_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2125","author":"SV Shmelkov","year":"2010","unstructured":"Shmelkov SV, Hormigo A, Jing D, et al. Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice. Nat Med. 2010. https:\/\/doi.org\/10.1038\/nm.2125.","journal-title":"Nat Med"},{"key":"721_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2016.232","author":"M Ullrich","year":"2018","unstructured":"Ullrich M, Weber M, Post AM, et al. OCD-like behavior is caused by dysfunction of thalamo-amygdala circuits and upregulated TrkB\/ERK-MAPK signaling as a result of SPRED2 deficiency. Mol Psychiatry. 2018. https:\/\/doi.org\/10.1038\/mp.2016.232.","journal-title":"Mol Psychiatry"},{"key":"721_CR15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1704547114","author":"M Rapanelli","year":"2017","unstructured":"Rapanelli M, Frick L, Bito H, Pittenger C. Histamine modulation of the basal ganglia circuitry in the development of pathological grooming. Proc Natl Acad Sci USA. 2017. https:\/\/doi.org\/10.1073\/pnas.1704547114.","journal-title":"Proc Natl Acad Sci USA"},{"key":"721_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/nature09965","author":"J Pe\u00e7a","year":"2011","unstructured":"Pe\u00e7a J, Feliciano C, Ting JT, Wang W, Wells MF, Venkatraman TN, Lascola CD, Fu Z, Feng G. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature. 2011. https:\/\/doi.org\/10.1038\/nature09965.","journal-title":"Nature"},{"key":"721_CR17","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1126\/science.1232380","volume":"340","author":"E Burgui\u00e8re","year":"2013","unstructured":"Burgui\u00e8re E, Monteiro P, Feng G, Graybiel AM. Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors. Science. 2013;340:1243\u20136.","journal-title":"Science"},{"key":"721_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1517","author":"E Kim","year":"2004","unstructured":"Kim E, Sheng M. PDZ domain proteins of synapses. Nat Rev Neurosci. 2004. https:\/\/doi.org\/10.1038\/nrn1517.","journal-title":"Nat Rev Neurosci"},{"key":"721_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3992","author":"T Bourgeron","year":"2015","unstructured":"Bourgeron T. From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nat Rev Neurosci. 2015. https:\/\/doi.org\/10.1038\/nrn3992.","journal-title":"Nat Rev Neurosci"},{"key":"721_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/nrn.2016.18","author":"J Zhu","year":"2016","unstructured":"Zhu J, Shang Y, Zhang M. Mechanistic basis of MAGUK-organized complexes in synaptic development and signalling. Nat Rev Neurosci. 2016. https:\/\/doi.org\/10.1038\/nrn.2016.18.","journal-title":"Nat Rev Neurosci"},{"key":"721_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.11.107","author":"J Zhu","year":"2017","unstructured":"Zhu J, Zhou Q, Shang Y, et al. Synaptic targeting and function of SAPAPs mediated by phosphorylation-dependent binding to PSD-95 MAGUKs. Cell Rep. 2017. https:\/\/doi.org\/10.1016\/j.celrep.2017.11.107.","journal-title":"Cell Rep"},{"key":"721_CR22","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.biopsych.2016.04.023","volume":"80","author":"KK Ade","year":"2016","unstructured":"Ade KK, Wan Y, Hamann HC, et al. Increased metabotropic glutamate receptor 5 signaling underlies obsessive-compulsive disorder-like behavioral and striatal circuit abnormalities in mice. Biol Psychiatry. 2016;80:522\u201333.","journal-title":"Biol Psychiatry"},{"key":"721_CR23","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1701-11.2011","author":"M Chen","year":"2011","unstructured":"Chen M, Wan Y, Ade K, Ting J, Feng G, Calakos N. Sapap3 deletion anomalously activates short-term endocannabinoid-mediated synaptic plasticity. J Neurosci. 2011. https:\/\/doi.org\/10.1523\/JNEUROSCI.1701-11.2011.","journal-title":"J Neurosci"},{"key":"721_CR24","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.biopsych.2013.01.008","volume":"75","author":"Y Wan","year":"2014","unstructured":"Wan Y, Ade KK, Caffall Z, Ilcim Ozlu M, Eroglu C, Feng G, Calakos N. Circuit-selective striatal synaptic dysfunction in the Sapap3 knockout mouse model of obsessive-compulsive disorder. Biol Psychiatry. 2014;75:623\u201330.","journal-title":"Biol Psychiatry"},{"key":"721_CR25","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1728-18.2018","author":"VL Corbit","year":"2019","unstructured":"Corbit VL, Manning EE, Gittis AH, Ahmari SE. Strengthened inputs from secondary motor cortex to striatum in a mouse model of compulsive behavior. J Neurosci. 2019. https:\/\/doi.org\/10.1523\/JNEUROSCI.1728-18.2018.","journal-title":"J Neurosci"},{"key":"721_CR26","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2533-11.2011","author":"Y Wan","year":"2011","unstructured":"Wan Y, Feng G, Calakos N. Sapap3 deletion causes mGluR5-dependent silencing of AMPAR synapses. J Neurosci. 2011. https:\/\/doi.org\/10.1523\/JNEUROSCI.2533-11.2011.","journal-title":"J Neurosci"},{"key":"721_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108160","author":"D Glorie","year":"2020","unstructured":"Glorie D, Verhaeghe J, Miranda A, Kertesz I, Wyffels L, Stroobants S, Staelens S. Progression of obsessive compulsive disorder-like grooming in Sapap3 knockout mice: a longitudinal [11C]ABP688 PET study. Neuropharmacology. 2020. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108160.","journal-title":"Neuropharmacology"},{"key":"721_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf6667","author":"SJ Finnema","year":"2016","unstructured":"Finnema SJ, Nabulsi NB, Eid T, et al. Imaging synaptic density in the living human brain. Sci Transl Med. 2016. https:\/\/doi.org\/10.1126\/scitranslmed.aaf6667.","journal-title":"Sci Transl Med"},{"key":"721_CR29","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.168179","author":"NB Nabulsi","year":"2016","unstructured":"Nabulsi NB, Mercier J, Holden D, et al. Synthesis and preclinical evaluation of 11C-UCB-J as a PET tracer for imaging the synaptic vesicle glycoprotein 2A in the brain. J Nucl Med. 2016. https:\/\/doi.org\/10.2967\/jnumed.115.168179.","journal-title":"J Nucl Med"},{"key":"721_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2019.02.003","author":"K Ciruelas","year":"2019","unstructured":"Ciruelas K, Marcotulli D, Bajjalieh SM. Synaptic vesicle protein 2: a multi-faceted regulator of secretion. Semin Cell Dev Biol. 2019. https:\/\/doi.org\/10.1016\/j.semcdb.2019.02.003.","journal-title":"Semin Cell Dev Biol"},{"key":"721_CR31","doi-asserted-by":"publisher","DOI":"10.1177\/0271678x19864081","author":"D Bertoglio","year":"2019","unstructured":"Bertoglio D, Verhaeghe J, Miranda A, et al. Validation and noninvasive kinetic modeling of [11 C]UCB-J PET imaging in mice. J Cereb Blood Flow Metab. 2019. https:\/\/doi.org\/10.1177\/0271678x19864081.","journal-title":"J Cereb Blood Flow Metab"},{"key":"721_CR32","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-neuro-062111-150442","author":"JT Ting","year":"2012","unstructured":"Ting JT, Pe\u00e7a J, Feng G. Functional consequences of mutations in postsynaptic scaffolding proteins and relevance to psychiatric disorders. Annu Rev Neurosci. 2012. https:\/\/doi.org\/10.1146\/annurev-neuro-062111-150442.","journal-title":"Annu Rev Neurosci"},{"key":"721_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2008.83","author":"S Z\u00fcchner","year":"2009","unstructured":"Z\u00fcchner S, Wendland JR, Ashley-Koch AE, et al. Multiple rare SAPAP3 missense variants in trichotillomania and OCD. Mol Psychiatry. 2009. https:\/\/doi.org\/10.1038\/mp.2008.83.","journal-title":"Mol Psychiatry"},{"key":"721_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2014.43","author":"M Mattheisen","year":"2015","unstructured":"Mattheisen M, Samuels JF, Wang Y, et al. Genome-wide association study in obsessive-compulsive disorder: results from the OCGAS. Mol Psychiatry. 2015. https:\/\/doi.org\/10.1038\/mp.2014.43.","journal-title":"Mol Psychiatry"},{"key":"721_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.30897","author":"OJ Bienvenu","year":"2009","unstructured":"Bienvenu OJ, Wang Y, Shugart YY, et al. Sapap3 and pathological grooming in humans: results from the OCD collaborative genetics study. Am J Med Genet Part B Neuropsychiatr Genet. 2009. https:\/\/doi.org\/10.1002\/ajmg.b.30897.","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet"},{"key":"721_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2012.85","author":"SE Stewart","year":"2013","unstructured":"Stewart SE, Yu D, Scharf JM, et al. Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry. 2013. https:\/\/doi.org\/10.1038\/mp.2012.85.","journal-title":"Mol Psychiatry"},{"key":"721_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2886","author":"HJ Kang","year":"2012","unstructured":"Kang HJ, Voleti B, Hajszan T, et al. Decreased expression of synapse-related genes and loss of synapses in major depressive disorder. Nat Med. 2012. https:\/\/doi.org\/10.1038\/nm.2886.","journal-title":"Nat Med"},{"key":"721_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2012.02.002","author":"SGN Grant","year":"2012","unstructured":"Grant SGN. Synaptopathies: diseases of the synaptome. Curr Opin Neurobiol. 2012. https:\/\/doi.org\/10.1016\/j.conb.2012.02.002.","journal-title":"Curr Opin Neurobiol"},{"key":"721_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2017.11.016","author":"AA Coley","year":"2018","unstructured":"Coley AA, Gao WJ. PSD95: a synaptic protein implicated in schizophrenia or autism? Prog Neuropsychopharmacol Biol Psychiatry. 2018. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.11.016.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"721_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/nature16549","author":"A Sekar","year":"2016","unstructured":"Sekar A, Bialas AR, De Rivera H, et al. Schizophrenia risk from complex variation of complement component 4. Nature. 2016. https:\/\/doi.org\/10.1038\/nature16549.","journal-title":"Nature"},{"key":"721_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09562-7","author":"SE Holmes","year":"2019","unstructured":"Holmes SE, Scheinost D, Finnema SJ, et al. Lower synaptic density is associated with depression severity and network alterations. Nat Commun. 2019. https:\/\/doi.org\/10.1038\/s41467-019-09562-7.","journal-title":"Nat Commun"},{"key":"721_CR42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0308208101","author":"BA Lynch","year":"2004","unstructured":"Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, Fuks B. The synaptic vesicle is the protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA. 2004. https:\/\/doi.org\/10.1073\/pnas.0308208101.","journal-title":"Proc Natl Acad Sci USA"},{"key":"721_CR43","first-page":"22","volume":"11","author":"M Sherer","year":"2008","unstructured":"Sherer M, Padilla S. A case of obsessiveness induced by levetiracetam in a patient with epilepsy, intellectual disability and pervasive developmental disorder. Ment Heal Asp Dev Disabil. 2008;11:22\u20136.","journal-title":"Ment Heal Asp Dev Disabil"},{"key":"721_CR44","doi-asserted-by":"publisher","DOI":"10.1080\/24750573.2017.1342798","author":"FP \u00c7\u00f6km\u00fc\u015f","year":"2017","unstructured":"\u00c7\u00f6km\u00fc\u015f FP, A\u015f\u00e7\u0131ba\u015f\u0131 K, \u00d6ztekin S, Demet MM. Relationship of levetiracetam and obsessive-compulsive disorder: a case report. Psychiatry Clin Psychopharmacol. 2017. https:\/\/doi.org\/10.1080\/24750573.2017.1342798.","journal-title":"Psychiatry Clin Psychopharmacol"},{"key":"721_CR45","doi-asserted-by":"publisher","DOI":"10.1177\/0883073814541471","author":"M Fujikawa","year":"2015","unstructured":"Fujikawa M, Kishimoto Y, Kakisaka Y, Jin K, Kato K, Iwasaki M, Nakasato N. Obsessive-compulsive behavior induced by levetiracetam. J Child Neurol. 2015. https:\/\/doi.org\/10.1177\/0883073814541471.","journal-title":"J Child Neurol"},{"issue":"6","key":"721_CR46","first-page":"1045","volume":"3","author":"HR Khouzam","year":"2015","unstructured":"Khouzam HR. Levetiracetam treatment of refractory obsessive-compulsive disorder. Ann Psychiatry Ment Health. 2015;3(6):1045.","journal-title":"Ann Psychiatry Ment Health"},{"key":"721_CR47","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s002590050211","volume":"25","author":"SP Hume","year":"1998","unstructured":"Hume SP, Gunn RN, Jones T. Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals. Eur J Nucl Med. 1998;25:173\u20136.","journal-title":"Eur J Nucl Med"},{"key":"721_CR48","doi-asserted-by":"publisher","DOI":"10.1258\/la.2012.011173","author":"AKO Alstrup","year":"2013","unstructured":"Alstrup AKO, Smith DF. Anaesthesia for positron emission tomography scanning of animal brains. Lab Anim. 2013. https:\/\/doi.org\/10.1258\/la.2012.011173.","journal-title":"Lab Anim"},{"key":"721_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2010.06.067","author":"GA Johnson","year":"2010","unstructured":"Johnson GA, Badea A, Brandenburg J, Cofer G, Fubara B, Liu S, Nissanov J. Waxholm space: an image-based reference for coordinating mouse brain research. Neuroimage. 2010. https:\/\/doi.org\/10.1016\/j.neuroimage.2010.06.067.","journal-title":"Neuroimage"},{"key":"721_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00516","author":"J Verhaeghe","year":"2018","unstructured":"Verhaeghe J, Bertoglio D, Kosten L, et al. Noninvasive relative quantification of [11C]ABP688 PET imaging in mice versus an input function measured over an arteriovenous shunt. Front Neurol. 2018. https:\/\/doi.org\/10.3389\/fneur.2018.00516.","journal-title":"Front Neurol"},{"key":"721_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1990.127","author":"J Logan","year":"1990","unstructured":"Logan J, Fowler JS, Volkow ND, et al. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab. 1990. https:\/\/doi.org\/10.1038\/jcbfm.1990.127.","journal-title":"J Cereb Blood Flow Metab"},{"key":"721_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2016.00566","author":"K Reemst","year":"2016","unstructured":"Reemst K, Noctor SC, Lucassen PJ, Hol EM. The indispensable roles of microglia and astrocytes during brain development. Front Hum Neurosci. 2016. https:\/\/doi.org\/10.3389\/fnhum.2016.00566.","journal-title":"Front Hum Neurosci"},{"key":"721_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.04.001","author":"H Lui","year":"2016","unstructured":"Lui H, Zhang J, Makinson SR, et al. Progranulin deficiency promotes circuit-specific synaptic pruning by microglia via complement activation. Cell. 2016. https:\/\/doi.org\/10.1016\/j.cell.2016.04.001.","journal-title":"Cell"},{"key":"721_CR54","doi-asserted-by":"publisher","DOI":"10.1172\/JCI80792","author":"T Dileepan","year":"2016","unstructured":"Dileepan T, Smith ED, Knowland D, et al. Group A Streptococcus intranasal infection promotes CNS infiltration by streptococcal-specific Th17 cells. J Clin Invest. 2016. https:\/\/doi.org\/10.1172\/JCI80792.","journal-title":"J Clin Invest"},{"key":"721_CR55","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8606057","author":"L Frick","year":"2016","unstructured":"Frick L, Pittenger C. Microglial Dysregulation in OCD, tourette syndrome, and PANDAS. J Immunol Res. 2016. https:\/\/doi.org\/10.1155\/2016\/8606057.","journal-title":"J Immunol Res"},{"key":"721_CR56","doi-asserted-by":"publisher","DOI":"10.31487\/j.nnb.2020.01.04","author":"C Cunha","year":"2020","unstructured":"Cunha C, Ashurov D, Todorov G, Mayilvahanan K. Dysregulation of DNA methylation during development as a potential mechanism contributing to obsessive compulsive disorders and autism. Neurol Neurobiol. 2020. https:\/\/doi.org\/10.31487\/j.nnb.2020.01.04.","journal-title":"Neurol Neurobiol"},{"key":"721_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45325-6","author":"G Todorov","year":"2019","unstructured":"Todorov G, Mayilvahanan K, Ashurov D, Cunha C. Amelioration of obsessive-compulsive disorder in three mouse models treated with one epigenetic drug: unraveling the underlying mechanism. Sci Rep. 2019. https:\/\/doi.org\/10.1038\/s41598-019-45325-6.","journal-title":"Sci Rep"},{"key":"721_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(97)00443-5","author":"DR Rosenberg","year":"1998","unstructured":"Rosenberg DR, Keshavan MS. Toward a neurodevelopmental model of obsessive-compulsive disorder. Biol Psychiatry. 1998. https:\/\/doi.org\/10.1016\/S0006-3223(97)00443-5.","journal-title":"Biol Psychiatry"},{"key":"721_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2009.01.003","author":"C Huyser","year":"2009","unstructured":"Huyser C, Veltman DJ, de Haan E, Boer F. Paediatric obsessive-compulsive disorder, a neurodevelopmental disorder? Evidence from neuroimaging. Neurosci Biobehav Rev. 2009. https:\/\/doi.org\/10.1016\/j.neubiorev.2009.01.003.","journal-title":"Neurosci Biobehav Rev"},{"key":"721_CR60","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2010.10040484","author":"M Feyder","year":"2010","unstructured":"Feyder M, Karlsson RM, Mathur P, et al. Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams\u2019 syndrome. Am J Psychiatry. 2010. https:\/\/doi.org\/10.1176\/appi.ajp.2010.10040484.","journal-title":"Am J Psychiatry"},{"key":"721_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2013.03.016","author":"YJ Hui","year":"2013","unstructured":"Hui YJ, Ehlers YJ. Modeling autism by SHANK gene mutations in Mice. Neuron. 2013. https:\/\/doi.org\/10.1016\/j.neuron.2013.03.016.","journal-title":"Neuron"},{"key":"721_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(01)00339-7","author":"C Sala","year":"2001","unstructured":"Sala C, Pi\u00ebch V, Wilson NR, Passafaro M, Liu G, Sheng M. Regulation of dendritic spine morphology and synaptic function by Shank and Homer. Neuron. 2001. https:\/\/doi.org\/10.1016\/S0896-6273(01)00339-7.","journal-title":"Neuron"},{"key":"721_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/nn1074","author":"C Dean","year":"2003","unstructured":"Dean C, Scholl FG, Choih J, DeMaria S, Berger J, Isacoff E, Scheiffele P. Neurexin mediates the assembly of presynaptic terminals. Nat Neurosci. 2003. https:\/\/doi.org\/10.1038\/nn1074.","journal-title":"Nat Neurosci"},{"key":"721_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/ng0610-478","author":"MW State","year":"2010","unstructured":"State MW. Another piece of the autism puzzle. Nat Genet. 2010. https:\/\/doi.org\/10.1038\/ng0610-478.","journal-title":"Nat Genet"},{"key":"721_CR65","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4517-09.2010","author":"J Blundell","year":"2010","unstructured":"Blundell J, Blaiss CA, Etherton MR, Espinosa F, Tabuchi K, Walz C, Bolliger MF, S\u00fcdhof TC, Powell CM. Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior. J Neurosci. 2010. https:\/\/doi.org\/10.1523\/JNEUROSCI.4517-09.2010.","journal-title":"J Neurosci"},{"key":"721_CR66","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.tics.2011.11.003","volume":"16","author":"MR Milad","year":"2012","unstructured":"Milad MR, Rauch SL. Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways. Trends Cogn Sci. 2012;16:43\u201351.","journal-title":"Trends Cogn Sci"},{"key":"721_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-14-87","author":"J Cr\u00e8vec\u0153ur","year":"2013","unstructured":"Cr\u00e8vec\u0153ur J, Foerch P, Doupagne M, Thielen C, Vandenplas C, Moonen G, Deprez M, Rogister B. Expression of SV2 isoforms during rodent brain development. BMC Neurosci. 2013. https:\/\/doi.org\/10.1186\/1471-2202-14-87.","journal-title":"BMC Neurosci"},{"key":"721_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2019.03.021","author":"A Vanoye-Carlo","year":"2019","unstructured":"Vanoye-Carlo A, G\u00f3mez-Lira G. Differential expression of SV2A in hippocampal glutamatergic and GABAergic terminals during postnatal development. Brain Res. 2019. https:\/\/doi.org\/10.1016\/j.brainres.2019.03.021.","journal-title":"Brain Res"},{"key":"721_CR69","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.228080","author":"A Mansur","year":"2020","unstructured":"Mansur A, Rabiner EA, Comley RA, Lewis Y, Middleton LT, Huiban M, Passchier J, Tsukada H, Gunn RN. Characterization of 3 PET tracers for quantification of mitochondrial and synaptic function in healthy human brain: 18F-BCPP-EF, 11C-SA-4503, and 11C-UCB-J. J Nucl Med. 2020. https:\/\/doi.org\/10.2967\/jnumed.119.228080.","journal-title":"J Nucl Med"},{"key":"721_CR70","first-page":"541","volume":"59","author":"R Carson","year":"2018","unstructured":"Carson R, Naganawa M, Matuskey D, et al. Age and sex effects on synaptic density in healthy humans as assessed with SV2A PET. J Nucl Med. 2018;59:541.","journal-title":"J Nucl Med"},{"key":"721_CR71","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X20931140","author":"MB Thomsen","year":"2020","unstructured":"Thomsen MB, Jacobsen J, Lillethorup TP, Schacht AC, Simonsen M, Romero-Ramos M, Brooks DJ, Landau AM. In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET. J Cereb Blood Flow Metab. 2020. https:\/\/doi.org\/10.1177\/0271678X20931140.","journal-title":"J Cereb Blood Flow Metab"},{"key":"721_CR72","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-020-01506-8","author":"MB Thomsen","year":"2020","unstructured":"Thomsen MB, Schacht AC, Alstrup AKO, et al. Preclinical PET studies of [11C]UCB-J binding in minipig brain. Mol Imaging Biol. 2020. https:\/\/doi.org\/10.1007\/s11307-020-01506-8.","journal-title":"Mol Imaging Biol"},{"key":"721_CR73","doi-asserted-by":"publisher","DOI":"10.1093\/ilar.48.4.356","author":"S Ramaswamy","year":"2007","unstructured":"Ramaswamy S, McBride JL, Kordower JH. Animal models of Huntington\u2019s disease. ILAR J. 2007. https:\/\/doi.org\/10.1093\/ilar.48.4.356.","journal-title":"ILAR J"},{"key":"721_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebcr.2013.11.002","author":"S Storrier","year":"2013","unstructured":"Storrier S, Beran RG. Compulsive gambling possibly associated with antiepileptic medication. Epilepsy Behav Case Reports. 2013. https:\/\/doi.org\/10.1016\/j.ebcr.2013.11.002.","journal-title":"Epilepsy Behav Case Reports"},{"key":"721_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2019.02.001","author":"K Heurling","year":"2019","unstructured":"Heurling K, Ashton NJ, Leuzy A, Zimmer ER, Blennow K, Zetterberg H, Eriksson J, Lubberink M, Sch\u00f6ll M. Synaptic vesicle protein 2A as a potential biomarker in synaptopathies. Mol Cell Neurosci. 2019. https:\/\/doi.org\/10.1016\/j.mcn.2019.02.001.","journal-title":"Mol Cell Neurosci"},{"key":"721_CR76","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.26.15268","author":"KM Crowder","year":"1999","unstructured":"Crowder KM, Gunther JM, Jones TA, Hale BD, Zhang HZ, Peterson MR, Scheller RH, Chavkin C, Bajjalieh SM. Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). Proc Natl Acad Sci USA. 1999. https:\/\/doi.org\/10.1073\/pnas.96.26.15268.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-020-00721-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13550-020-00721-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-020-00721-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T12:08:06Z","timestamp":1605269286000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-020-00721-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,13]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["721"],"URL":"https:\/\/doi.org\/10.1186\/s13550-020-00721-2","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,13]]},"assertion":[{"value":"24 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}